Get started
Genscript Biotech CorpGenscript Biotech CorpGenscript Biotech Corp

Genscript Biotech Corp

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.21 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−271.44 M‬ USD
Revenue (FY)
‪601.60 M‬ USD
Shares float
‪1.12 B‬
Beta (1Y)
1.65

Employees


Employees (FY)
‪5.57 K‬
Change (1Y)
‪−1.37 K‬ −19.73%
Revenue / Employee (1Y)
‪108.05 K‬ USD
Net income / Employee (1Y)
‪−12.12 K‬ USD

About Genscript Biotech Corporation


Sector
Health Technology
Industry
Biotechnology
CEO
Weihui Shao
Website
genscript.com
Headquarters
Nanjing
Founded
2002
ISIN
KYG3825B1059
FIGI
BBG00H8V6R36
Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services. The Precision Immune-cell Therapy segment discovers and develops therapies for the treatment of liquid tumour through optimised CAR structures and the development of bispecific CAR-T therapies. The Industrial Synthetic Biology Products segment comprises of the construction of non-pathogenic microbial strains and industrial enzyme development and production. The company was founded by Fang Liang Zhang, Lu Quan Wang, and Ye Wang in 2002 and is headquartered in Nanjing, China.

Check out other big names from the same industry as GNNSF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs


513120
GF CSI Hong Kong Brand Name Drug Exchange Traded Fund Units
Weight
2.63%
Market value
‪49.91 M‬
USD
VWO
Vanguard FTSE Emerging Markets ETF
Weight
0.02%
Market value
‪33.38 M‬
USD
159570
China Universal CNI HK Connect Innovative Drug ETF
Weight
2.36%
Market value
‪26.78 M‬
USD
IEMG
iShares Core MSCI Emerging Markets ETF
Weight
0.02%
Market value
‪23.62 M‬
USD
159636
ICBC Credit Suisse CNI HK Connect Technology ETF
Weight
0.46%
Market value
‪14.75 M‬
USD
159892
ChinaAMC Hang Seng Hong Kong-Listed Biotech Index ETF Units A
Weight
1.93%
Market value
‪12.24 M‬
USD
513980
INVESCO Great Wall CSI Hong Kong Connect Technology Index Exchange Traded Fund Units
Weight
0.55%
Market value
‪11.32 M‬
USD
159567
Yinhua China Sec Hong Kong Stock Connect Innovative Drug Etf
Weight
2.22%
Market value
‪9.16 M‬
USD
159506
Hang Seng Healthcare ETF
Weight
2.26%
Market value
‪7.02 M‬
USD
EIMI
iShares Core MSCI EM IMI UCITS ETF
Weight
0.02%
Market value
‪6.73 M‬
USD
EIMU
iShares Core MSCI EM IMI UCITS ETF
Weight
0.02%
Market value
‪6.73 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of GNNSF is 2.12 USD — it has decreased by −7.46% in the past 24 hours. Watch Genscript Biotech Corp stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Genscript Biotech Corp stocks are traded under the ticker GNNSF.
GNNSF stock has fallen by −7.46% compared to the previous week, the month change is a 16.48% rise, over the last year Genscript Biotech Corp has showed a 61.83% increase.
We've gathered analysts' opinions on Genscript Biotech Corp future price: according to them, GNNSF price has a max estimate of 3.37 USD and a min estimate of 2.77 USD. Watch GNNSF chart and read a more detailed Genscript Biotech Corp stock forecast: see what analysts think of Genscript Biotech Corp and suggest that you do with its stocks.
GNNSF reached its all-time high on Jul 19, 2021 with the price of 5.30 USD, and its all-time low was 0.89 USD and was reached on Sep 28, 2017. View more price dynamics on GNNSF chart.
See other stocks reaching their highest and lowest prices.
GNNSF stock is 8.07% volatile and has beta coefficient of 1.65. Track Genscript Biotech Corp stock price on the chart and check out the list of the most volatile stocks — is Genscript Biotech Corp there?
Today Genscript Biotech Corp has the market capitalization of ‪4.18 B‬, it has decreased by −3.05% over the last week.
Yes, you can track Genscript Biotech Corp financials in yearly and quarterly reports right on TradingView.
Genscript Biotech Corp is going to release the next earnings report on Mar 27, 2026. Keep track of upcoming events with our Earnings Calendar.
GNNSF earnings for the last half-year are −0.02 USD per share, whereas the estimation was 0.08 USD, resulting in a −127.00% surprise. The estimated earnings for the next half-year are −0.01 USD per share. See more details about Genscript Biotech Corp earnings.
Genscript Biotech Corp revenue for the last half-year amounts to ‪518.77 M‬ USD, despite the estimated figure of ‪560.39 M‬ USD. In the next half-year revenue is expected to reach ‪441.15 M‬ USD.
GNNSF net income for the last half-year is ‪−25.27 M‬ USD, while the previous report showed ‪−175.30 M‬ USD of net income which accounts for 85.59% change. Track more Genscript Biotech Corp financial stats to get the full picture.
No, GNNSF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 6, 2025, the company has ‪5.57 K‬ employees. See our rating of the largest employees — is Genscript Biotech Corp on this list?
Like other stocks, GNNSF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Genscript Biotech Corp stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Genscript Biotech Corp technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Genscript Biotech Corp stock shows the buy signal. See more of Genscript Biotech Corp technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.